Item
8.01 Other
Events.
On
October 29, 2009, Generex Biotechnology Corporation (the “Company”) issued a
press release to announce that in light of general market conditions, the
Company will not exercise its right to issue and sell shares of its common
stock, par value $.001 per share, under that certain At Market Issuance Sales
Agreement entered into by and between the Company and Wm Smith & Co. on
October 14, 2009 until further notice. A copy of the press release is
attached hereto as Exhibit 99.1 and incorporated herein by
reference.
Item 9.01
Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
|
Exhibit
Number
|
Description
|
|
|
99.1
|
Press
release issued by Generex Biotechnology Corporation dated October 29,
2009
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
GENEREX
BIOTECHNOLOGY CORPORATION.
|
||||||
|
Date:
October 30, 2009
|
/s/
Rose C. Perri
|
|||||
|
Chief
Operating Officer and Chief Financial Officer
(principal
financial officer)
|
||||||
EXHIBIT
INDEX
|
Exhibit
Number
|
Description
|
|
|
99.1
|
Press
release issued by Generex Biotechnology Corporation dated October 29,
2009
|
|